Subscribe To
Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual
CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...
March 8, 2022, 5:01 pm
Theseus pharmaceuticals to present preclinical data characterizing next-generation epidermal growth factor receptor (egfr) inhibitors at the 2022 american association for cancer research (aacr) annual
CAMBRIDGE, Mass., March 8, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceut...
March 8, 2022, 5:01 pm
Jazz pharmaceuticals to present pan-raf inhibitor pre-clinical data at american association for cancer research (aacr) 2022 annual meeting
DUBLIN, March 8, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that pre-clinical data on JZP815, an investigational, ne...
March 8, 2022, 4:35 pm
Ikena oncology to present preclinical findings on ik-930, a novel tead inhibitor at the 2022 american association for cancer research (aacr) annual meeting
BOSTON, March 07, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA), a targeted oncology company navigating new territory in patient-direct...
March 7, 2022, 4:30 pm
Vyne therapeutics' bet inhibitor shows encouraging preclinical action in skin disorder
VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disor...
March 7, 2022, 12:06 pm
Vyne therapeutics' bet inhibitor shows encouraging preclinical action in skin disorder
VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disor...
March 7, 2022, 12:06 pm
Vyne therapeutics' bet inhibitor shows encouraging preclinical action in skin disorder
VYNE Therapeutics Inc (NASDAQ: VYNE) has announced preclinical data in an ex vivo skin model of vitiligo, a chronic autoimmune depigmenting disor...
March 7, 2022, 12:06 pm
Cinemark to participate in morgan stanley investor conference
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibito...
March 3, 2022, 5:58 pm
Cinemark to participate in morgan stanley investor conference
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibito...
March 3, 2022, 5:58 pm
Cinemark to participate in morgan stanley investor conference
PLANO, Texas--(BUSINESS WIRE)--Cinemark Holdings, Inc. (NYSE: CNK), one of the largest motion picture exhibito...
March 3, 2022, 5:58 pm
Annexon biosciences to present preclinical data supporting complement inhibitor programs for the treatment of guillain-barré syndrome and huntington's disease at aan 2022
BRISBANE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developi...
March 3, 2022, 4:01 pm
Annexon biosciences to present preclinical data supporting complement inhibitor programs for the treatment of guillain-barré syndrome and huntington's disease at aan 2022
BRISBANE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developi...
March 3, 2022, 4:01 pm
Annexon biosciences to present preclinical data supporting complement inhibitor programs for the treatment of guillain-barré syndrome and huntington's disease at aan 2022
BRISBANE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developi...
March 3, 2022, 4:01 pm
Gilead gets a complete response letter from fda about the vial used to store an experimental hiv drug
Shares of Gilead Sciences Inc. GILD, -1.18% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response lett...
March 1, 2022, 9:22 am
Gilead gets a complete response letter from fda about the vial used to store an experimental hiv drug
Shares of Gilead Sciences Inc. GILD, -1.18% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response lett...
March 1, 2022, 9:22 am
Gilead gets a complete response letter from fda about the vial used to store an experimental hiv drug
Shares of Gilead Sciences Inc. GILD, -1.18% were down 1.0% in premarket trading on Tuesday after the company said it received a complete response lett...
March 1, 2022, 9:22 am
Cortexyme: a biotech worth a look based on potential alzheimer's treatment
COR588 is the second-generation lysine gingipain inhibitor which is being developed to treat Alzheimer'...
February 28, 2022, 9:15 pm
Cortexyme: a biotech worth a look based on potential alzheimer's treatment
COR588 is the second-generation lysine gingipain inhibitor which is being developed to treat Alzheimer'...
February 28, 2022, 9:15 pm
Cortexyme: a biotech worth a look based on potential alzheimer's treatment
COR588 is the second-generation lysine gingipain inhibitor which is being developed to treat Alzheimer'...
February 28, 2022, 9:15 pm
Olympic steel, inc. (zeus) ceo richard marabito on q4 2021 results - earnings call transcript
Olympic Steel, Inc. (ZEUS) CEO Richard Marabito on Q4 2021 Results - Earnings Call Transcript...
February 25, 2022, 2:42 pm